160 HEALTH (02656) announced its allocation results, with the company conducting a global offering of 33.6455 million shares. The Hong Kong public offering accounts for 10% while the international offering represents 90% of the total. The final offer price was set at HK$11.89 per share, with the global offering raising net proceeds of approximately HK$316 million. With a board lot of 250 shares, the shares are expected to commence trading on the Stock Exchange of Hong Kong at 9:00 a.m. on Wednesday, September 17, 2025. The Hong Kong public offering received oversubscription of 751.77 times, while the international offering was oversubscribed by 1.92 times.